Invest now
Natco Pharma Profit & Loss Annual
BSE: 524816 | NSE: NATCOPHARM | ISIN: INE987B01026 | Sector: Biotechnology & Drugs819.00 0.00 (0.00%)Updated : 11 Sep 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Operating Expense | 2,823.30 | 2,468.70 | 2,431.40 | 1,930.10 |
| Other Net | 15.70 | 41.60 | 8.90 | 9.10 |
| Diluted Weighted Average Shares | 17.91 | 17.91 | 17.95 | 18.26 |
| Gain( Loss)on Saleof Assets | -25.10 | 90.10 | -1.70 | 17.80 |
| Depreciation/ Amortization | 206.10 | 185.20 | 186.80 | 163.80 |
| Operating Income | 1,255.00 | 1,960.80 | 1,567.40 | 777.00 |
| Net Income | 1,418.50 | 1,885.40 | 1,388.30 | 715.30 |
| Income Availableto Com Excl Extra Ord | 1,418.50 | 1,885.40 | 1,388.30 | 715.30 |
| Other Operating Expenses Total | 64.90 | 20.40 | 30.90 | 11.40 |
| Net Income Before Taxes | 1,490.80 | 2,291.40 | 1,673.50 | 861.90 |
| Minority Interest | 0.00 | 2.00 | 0.00 | 0.00 |
| Net Income After Taxes | 1,371.90 | 1,883.40 | 1,388.30 | 715.30 |
| Income Availableto Com Incl Extra Ord | 1,418.50 | 1,885.40 | 1,388.30 | 715.30 |
| Costof Revenue Total | 895.40 | 848.30 | 865.60 | 749.10 |
| Gross Profit | 3,182.90 | 3,581.20 | 3,133.20 | 1,958.00 |
| Interest Inc( Exp) Net- Non- Op Total | 245.20 | 198.90 | 98.90 | 58.00 |
| Unusual Expense( Income) | 0.50 | 50.00 | 0.00 | 2.30 |
| Diluted Net Income | 1,418.50 | 1,885.40 | 1,388.30 | 715.30 |
| DPS- Common Stock Primary Issue | 5.00 | 6.00 | 9.50 | 5.50 |
| Provisionfor Income Taxes | 118.90 | 408.00 | 285.20 | 146.60 |
| Equity In Affiliates | 46.60 | - | - | - |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 1,418.50 | 1,885.40 | 1,388.30 | 715.30 |
| Total Revenue | 4,078.30 | 4,429.50 | 3,998.80 | 2,707.10 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 4,078.30 | 4,429.50 | 3,998.80 | 2,707.10 |
| Selling/ General/ Admin Expenses Total | 1,452.00 | 1,260.80 | 1,227.00 | 914.30 |
| Diluted Normalized EPS | 80.51 | 103.42 | 77.42 | 38.48 |
| Research Development | 204.40 | 104.00 | 121.10 | 89.20 |
| Diluted EPS Excluding Extra Ord Items | 79.20 | 105.27 | 77.34 | 39.18 |
*All figures in crores except per share values
Natco Pharma Quick Links
Natco Pharma Dividend Natco Pharma Bonus Natco Pharma News Natco Pharma AGM Natco Pharma Rights Natco Pharma Splits Natco Pharma Board Meetings Natco Pharma Key Metrics Natco Pharma Shareholdings Natco Pharma Balance Sheet Natco Pharma Cashflow Natco Pharma Q1 Results Natco Pharma Q2 Results Natco Pharma Q3 Results Natco Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
272.00+6.05(2.27%)
1,260.00+20.50(1.65%)
11,053.00+157.00(1.44%)
1,196.80-29.75 (-2.43%)
185.95-2.60 (-1.38%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.